SBIR-STTR Award

Bronchoscopic lung navigation system for accurately excising lung nodules
Award last edited on: 5/19/2023

Sponsored Program
STTR
Awarding Agency
NIH : NCI
Total Award Amount
$399,975
Award Phase
2
Solicitation Topic Code
394
Principal Investigator
Jayender Jagadeesan

Company Information

Navigation Sciences Inc

404 Clinton Road
Brookline, MA 02445
   (617) 834-2829
   info@navigationsci.com
   www.navigationsci.com

Research Institution

----------

Phase I

Contract Number: 1R41CA261420-01A1
Start Date: 9/2/2021    Completed: 8/31/2023
Phase I year
2021
Phase I Amount
$324,002
The long-term goal of this project is to develop and commercialize a navigation system that can accurately determine margins in real-time during surgery for lung cancer. Surgery is currently the standard of care for early stage lung cancer. A critical challenge is to reliably identify small, early-stage tumors and resect them with sufficient margins (distance between the edge of tumor and the line of resection). Too close a margin is associated with a higher incidence of recurrence and death. To address this challenge, this team developed a new surgical procedure called image-guided video thoracoscopic surgery (iVATS), in which the surgeon localizes and resects small lung nodules by marking them percutaneously using a fiducial marker, a small passive metal tag called T-bar, placed under C-arm CT image-guidance. A novel navigation technology, NaviSci™, was developed to aid in identifying and removing lung tumors by using an active sensing nodule marker, called J- Bar, that is placed in the lung just next to the tumor and can track the tumor position in real-time and help assess margins. However, use of the J-Bar requires either intraoperative imaging or approximate visual positioning of very small tumors that may not be visible during surgery from the lung surface. Navigation Sciences is now developing a tumor marker that can be positioned with a bronchoscope and does not require CT imaging during surgery. The objective of this Phase I STTR project is to develop and validate the NaviSci-EndoMarkerTM (called EndoMarker hereafter) to accurately localize small lung tumors. The EndoMarker will be positioned adjacent to the tumor with a bronchoscope based on navigation planned using diagnostic CT images. This will simplify the clinical workflow and make this procedure accessible to hospitals that do not have advanced intra-operative imaging technologies. Aim 1 is to design and develop the bronchoscopic EndoMarker. Aim 2 is to validate the workflow for deploying the EndoMarker, mechanical stability, and electrical isolation of the EndoMarker in a 3D printed lung phantom, ex vivo porcine lungs and 2 live pigs. This STTR project is a collaboration between Navigation Sciences and ongoing collaborators at the Brigham and Women’s Hospital (Boston, MA). The proposed R&D project is significant since it addresses an important problem of accurately localizing and resecting lung nodules while preserving healthy lung function, which could benefit thousands of patients each year. The novelty lies in the design of the EndoMarker, which will allow the J-Bar marker to be placed accurately via a bronchoscope so that it can readily localize small tumors and define their margins during surgery. Successful completion of this project will result in an innovative disruptive product that will provide surgical guidance to ensure sufficient resection of early-stage lung cancer with acceptable margins without any additional imaging equipment at the medical center.

Public Health Relevance Statement:
NARRATIVE This project will develop a novel surgical marking device to localize small lung tumors so they can be found and removed, with safe margins, in surgical procedures that preserve healthy lung tissue and function. The marking device can be positioned before surgery and will not require the use of advanced imaging technologies during surgery. Because modern screening methods identify lung cancer at an early stage when the tumors are very small and easier to remove, this tool will benefit thousands of patients each year.

Project Terms:
Boston ; Couples ; Cessation of life ; Death ; Electromagnetics ; Equipment ; Future ; Goals ; Hospitals ; Incidence ; Lung ; Lung Respiratory System ; pulmonary ; Lung Neoplasms ; Lung Tumor ; Pulmonary Neoplasms ; Metals ; Methods ; Modernization ; Needles ; Nodule ; Patients ; Lung nodule ; pulmonary nodule ; Recurrence ; Recurrent ; research and development ; Development and Research ; R & D ; R&D ; Robotics ; Science ; Signal Transduction ; Cell Communication and Signaling ; Cell Signaling ; Intracellular Communication and Signaling ; Signal Transduction Systems ; Signaling ; biological signal transduction ; Surgical Staplers ; Family suidae ; Pigs ; Suidae ; Swine ; porcine ; suid ; Technology ; Time ; X-Ray Computed Tomography ; CAT scan ; CT X Ray ; CT Xray ; CT imaging ; CT scan ; Computed Tomography ; Tomodensitometry ; X-Ray CAT Scan ; X-Ray Computerized Tomography ; Xray CAT scan ; Xray Computed Tomography ; Xray computerized tomography ; catscan ; computed axial tomography ; computer tomography ; computerized axial tomography ; computerized tomography ; Tumor Markers ; TM-MKR ; tumor biomarker ; tumor specific biomarker ; Woman ; Measures ; Health Care Costs ; Health Costs ; Healthcare Costs ; TimeLine ; base ; Bronchoscopes ; sensor ; Procedures ; Surface ; Clinical ; Phase ; Ensure ; pulmonary function ; lung function ; Visual ; Malignant neoplasm of lung ; Malignant Tumor of the Lung ; Pulmonary Cancer ; Pulmonary malignant Neoplasm ; lung cancer ; Collaborations ; tool ; instrument ; Diagnostic ; mechanical ; Mechanics ; Location ; Thoracic Surgery ; chest surgery ; Thoracic Surgical Procedures ; Operative Procedures ; Surgical ; Surgical Interventions ; Surgical Procedure ; surgery ; Operative Surgical Procedures ; Medical center ; Surgeon ; Performance ; lung preservation ; novel ; Devices ; Abscission ; Extirpation ; Removal ; Surgical Removal ; resection ; Excision ; Position ; Positioning Attribute ; Thoracoscopic Surgery ; Thoracoscopic Surgical Procedures ; Video-Assisted Thoracoscopic Surgery ; Video-Assisted Thoracic Surgery ; Lung Parenchyma ; Lung Tissue ; Structure of parenchyma of lung ; develop software ; developing computer software ; software development ; cancer diagnosis ; intra-operative imaging ; intraoperative imaging ; surgical imaging ; Image-Guided Surgery ; T-Stage ; Tumor stage ; Address ; Ph.D. ; PhD ; Doctor of Philosophy ; Small Business Technology Transfer Research ; STTR ; Validation ; Development ; developmental ; Image ; imaging ; preclinical study ; pre-clinical study ; design ; designing ; Outcome ; manufacturing process ; Imaging technology ; Navigation System ; innovation ; innovate ; innovative ; tumor ; minimally invasive ; standard of care ; arm ; screening ; 3D Print ; 3-D print ; 3-D printer ; 3D printer ; 3D printing ; three dimensional printing ; image guided ; image guidance ; imaging capabilities ; preservation ; low dose computed tomography ; low dose computerized tomography ; low-dose CT ;

Phase II

Contract Number: 5R41CA261420-02
Start Date: 9/2/2021    Completed: 8/31/2023
Phase II year
2022
Phase II Amount
$75,973
The long-term goal of this project is to develop and commercialize a navigation system that can accuratelydetermine margins in real-time during surgery for lung cancer. Surgery is currently the standard of care for earlystage lung cancer. A critical challenge is to reliably identify small, early-stage tumors and resect them withsufficient margins (distance between the edge of tumor and the line of resection). Too close a margin isassociated with a higher incidence of recurrence and death. To address this challenge, this team developed anew surgical procedure called image-guided video thoracoscopic surgery (iVATS), in which the surgeon localizesand resects small lung nodules by marking them percutaneously using a fiducial marker, a small passive metaltag called T-bar, placed under C-arm CT image-guidance. A novel navigation technology, NaviSci™, wasdeveloped to aid in identifying and removing lung tumors by using an active sensing nodule marker, called J-Bar, that is placed in the lung just next to the tumor and can track the tumor position in real-time and help assessmargins. However, use of the J-Bar requires either intraoperative imaging or approximate visual positioning ofvery small tumors that may not be visible during surgery from the lung surface.Navigation Sciences is now developing a tumor marker that can be positioned with a bronchoscope and doesnot require CT imaging during surgery. The objective of this Phase I STTR project is to develop and validate theNaviSci-EndoMarkerTM (called EndoMarker hereafter) to accurately localize small lung tumors. TheEndoMarker will be positioned adjacent to the tumor with a bronchoscope based on navigation planned usingdiagnostic CT images. This will simplify the clinical workflow and make this procedure accessible to hospitalsthat do not have advanced intra-operative imaging technologies. Aim 1 is to design and develop thebronchoscopic EndoMarker. Aim 2 is to validate the workflow for deploying the EndoMarker, mechanical stability,and electrical isolation of the EndoMarker in a 3D printed lung phantom, ex vivo porcine lungs and 2 live pigs.This STTR project is a collaboration between Navigation Sciences and ongoing collaborators at the Brigham andWomen's Hospital (Boston, MA). The proposed R&D project is significant since it addresses an importantproblem of accurately localizing and resecting lung nodules while preserving healthy lung function, which couldbenefit thousands of patients each year. The novelty lies in the design of the EndoMarker, which will allow theJ-Bar marker to be placed accurately via a bronchoscope so that it can readily localize small tumors and definetheir margins during surgery. Successful completion of this project will result in an innovative disruptive productthat will provide surgical guidance to ensure sufficient resection of early-stage lung cancer with acceptablemargins without any additional imaging equipment at the medical center.

Public Health Relevance Statement:
NARRATIVE This project will develop a novel surgical marking device to localize small lung tumors so they can be found and removed, with safe margins, in surgical procedures that preserve healthy lung tissue and function. The marking device can be positioned before surgery and will not require the use of advanced imaging technologies during surgery. Because modern screening methods identify lung cancer at an early stage when the tumors are very small and easier to remove, this tool will benefit thousands of patients each year.

Project Terms: